Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Vijaya Diagnostic Centre Ltd. ( (IN:VIJAYA) ) has provided an update.
Vijaya Diagnostic Centre Ltd. has announced that its shareholders have approved the appointment of Mr. Ravi Shankararamiah and Dr. Sasikala Paruchuri Kola as independent directors, following a postal ballot process conducted via remote e-voting. The resolutions, treated as special business under securities regulations, were passed with the requisite majority, reinforcing the company’s board independence and governance framework, and the scrutinizer’s report and voting results have been formally submitted to the stock exchanges.
The approval of these independent directors is expected to strengthen oversight and provide additional expertise to the board, which may support the company’s strategic and compliance objectives in the regulated diagnostics sector. By successfully completing the postal ballot and disclosing the outcome in line with listing obligations, Vijaya Diagnostic Centre underlines its adherence to corporate governance norms, offering greater transparency and assurance to investors and other stakeholders.
More about Vijaya Diagnostic Centre Ltd.
Vijaya Diagnostic Centre Ltd. operates in the healthcare diagnostics industry, providing pathology and radiology testing services through a network of diagnostic centres. The company focuses on serving patients and healthcare providers in India, offering a range of medical testing and imaging services to support clinical decision-making and treatment.
Average Trading Volume: 16,109
Technical Sentiment Signal: Buy
Current Market Cap: 131.3B INR
For detailed information about VIJAYA stock, go to TipRanks’ Stock Analysis page.